Upcoming Dividend Alert: Pharma Announces 800% Dividend For Shareholders; Should You Buy Before Record Date?

Cipla Dividend: Global pharmaceutical company, Cipla, shares are trading lower ahead of the company's dividend record date. Cipla in May announced an 800% dividend for its shareholders and has fixed June 27 as the record date.

Cipla shares were trading marginally lower at Rs 1497.45 per share on BSE at 1:50 pm on Monday, June 23. The company's stock market capitalisation stood at Rs 1,20,889.63 crore.

Cipla Dividend

The BSE 100 pharma company had announced a final dividend of Rs 13 per equity share and a special dividend of Rs 3 per equity share for its shareholders. Cipla dividend will be paid to shareholders within 30 days from the date of the Annual General Meeting.
"The Board of Directors of the Company also recommended a final dividend of INR 13/- per equity share for the financial year ended 31st March, 2025 and a special dividend of INR 3/- per equity share on the occasion of completing 90 years of the Company, taking the total dividend to INR 16/- per equity share (face value INR 2 each)," read a Cipla BSE exchange filing released on May 13 May.

Cipla Dividend Record Date

Cipla had fixed 27 June as dividend record date. A dividend record date is fixed by companies to determine the eligibility of their shareholders for corporate actions like dividend, bonus issue, stock split, etc.

"The dividend, upon approval by the shareholders, will be paid to shareholders within 30 days from the date of the Annual General Meeting. The record date for the purpose of payment of final dividend, if declared, shall be 27th June, 2025," Cipla added in its report.

Cipla Share Price Recommendation

Brokerage firm Antique has maintained a 'Buy' rating for Cipla stock and has fixed a target price of Rs 1760 per share, indicating an upside of 17%. The brokerage in its report mentioned that several pharmaceutical companies, including Cipla, are likely to benefit from the expansion of US generic market.

"We have seen companies like CIPLA implementing multi-site manufacturing for its US products, derisking its supply chain, and enhancing compliance. These efforts should help in reducing regulatory overhangs and improving supply reliability, which is critical for maintaining long-term customer relations in the US," noted Antique in its report.

Cipla Q4 Result

Cipla reported a 30% annual increase in its net profit during the March quarter, reaching Rs 1,222 crore for Q4FY25, compared to Rs 939 crore in the same quarter last year. Company's revenue from operations surged by 8.45% annually to Rs 6,597.72 crore, up from Rs 6,082.37 crore in the corresponding quarter of the previous fiscal.

Disclaimer: The write-up is just for information purposes, and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on article mentioned. Neither, the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.